Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Withdrawn before enrolling · Phase 4
Conditions studied: ADHD
In brief
The primary aim of this study is to assess the predictability of treatment response to stimulants in adults with ADHD using functional magnetic resonance This study will be a six-week, open-label study including adults ranging from age 18-55 with ADHD.
Key facts
- Study ID
- NCT01858064
- Run by
- Massachusetts General Hospital
- People needed
- 0
- Starts
- 2015-04-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2015-04-28
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female adults ages 18-55 years
- Right handed
- A diagnosis current of childhood onset ADHD, according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) based on clinical assessment
- A score of > 20 on the Adult ADHD Investigator Symptom Report Scale (AISRS) or a CGI-Severity score of > 4 (moderate severity)
You may not qualify if…
- A history of non-response or intolerance to stimulants at adequate doses as determined by the clinician
- Pregnant or nursing females
- Serious, unstable medical illnesses including hepatic, renal, gastroenterological, respiratory, cardiovascular, endocrinologic (thyroid), neurologic (seizure), immunologic, or hematologic disease
- Glaucoma
- Clinically unstable psychiatric conditions including suicidality, homocidality, bipolar disorder, psychosis, or lifetime history of a clinically serious condition potentially exacerbated by a stimulant, such as mania or psychosis
- Tics or diagnosis of Tourette's syndrome
- Current (within 3 months) DSM-IV criteria for abuse or dependence with any psychoactive substance other than nicotine
- Current use of psychotropic medications
- Current use of MAO Inhibitor or use within the past two weeks
- Claustrophobia or an standard contraindications to MRI scanning (metal in body)
- Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent or grandchild
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.